Lung Cancer Non Clinical
1. Hoe SLL, Lee ES, Khoo AS, et al. Lack of Rb2/p130 genetic alteration in Malaysian nasopharyngeal carcinoma. Malays J Pathol 2009;31(1):53-56 http://www.mjpath.org.my/2009.1/08Lack_Rb2_p130_genetic_alteration.pd f
2. Wong PF, Cheong WF, Shu MH, et al. Eurycomanone suppresses
expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine 2012;19(2):138-144. 3. Cheah PL, Looi LM. p53: an overview of over two decades of study. Malays
J Pathol 2001;23(1):9-16
http://www.mjpath.org.my/past_issue/MJP2001.1/P53%20an%20overview %20of%20over%20two%20decades%20of%20study.pdf.
4. Ooi KL, Muhammad TS, Tan ML, et al. Cytotoxic, apoptotic and anti-alpha-glucosidase activities of 3,4-di-O-caffeoyl quinic acid, an antioxidant isolated from the polyphenolic-rich extract of Elephantopus mollis Kunth. J Ethnopharmacol 2011;135(3):685-695.
5. Joshi SC, Pant I, Hamzah F, et al. Integrated positron emission
tomography/computed tomography fusion imaging: an emerging gold standard in lung cancer. Indian J Cancer 2008;45(4):137-141.
6. Sachithanandan A. eComment. Computed tomography surveillance of lung cancer survivors: the jury is still out. Interact Cardiovasc Thorac Surg 2012;15(5):898-899
